col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

248 Results       Page 1

Springer (Biomed Central Ltd.): BMC Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―15 COVID-19 inequalities in England: a mathematical modelling study of transmission risk and clinical vulnerability by socioeconomic status Lucy Goodfellow, Edwin van Leeuwen, Rosalind M. Eggo
2 [GO] 2024―Apr―15 What is quality in long covid care? Lessons from a national quality improvement collaborative and multi-site ethnography Trisha Greenhalgh, Julie L. Darbyshire, Cassie Lee, Emma Ladds, Jenny Ceolta-Smith
3 [GO] 2024―Mar―26 SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort Elisabeth Dietz, Emma Pritchard, Koen Pouwels, Muhammad Ehsaan, Joshua Blake, Charlotte Gaughan, et al. (+17)
4 [GO] 2024―Mar―22 Progress with the Learning Health System 2.0: a rapid review of Learning Health Systems’ responses to pandemics and climate change Carolynn L. Smith, Georgia Fisher, Putu Novi Arfirsta Dharmayani, Shalini Wijekulasuriya, Louise A. Ellis, Samantha Spanos, et al. (+3)
5 [GO] 2024―Mar―18 SARS-CoV-2 infection is detrimental to pregnancy outcomes after embryo transfer in IVF/ICSI: a prospective cohort study Yuan Li, Qi Zhao, Shujuan Ma, Sha Tang, Guangxiu Lu, Ge Lin, Fei Gong
6 [GO] 2024―Mar―14 Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis Ju Hwan Kim, Dongwon Yoon, Hwa Yeon Ko, Kyungyeon Jung, Jun-Sang Sunwoo, Won Chul Shin, et al. (+2)
7 [GO] 2024―Mar―13 Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review Chengchen Duan, Liu Liu, Tianyi Wang, Guanru Wang, Zhishen Jiang, Honglin Li, et al. (+4)
8 [GO] 2024―Mar―13 Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study Weijie Wang, Yu-Hsun Wang, Ching-Hua Huang, Tsung-Hsueh Hsieh, Gema Hernández Ibarburu, James Cheng-Chung Wei
9 [GO] 2024―Mar―07 Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up Yifei Lin, Yong Yang, Nanyan Xiang, Le Wang, Tao Zheng, Xuejun Zhuo, et al. (+6)
10 [GO] 2024―Mar―06 A self-controlled case series study to measure the risk of SARS-CoV-2 infection associated with attendance at sporting and cultural events: the UK Events Research Programme events Ian J. Douglas, Jerlyn Peh, Kathryn E. Mansfield, Anna Trelfa, Tom Fowler, Matthew Boulter, et al. (+3)
11 [GO] 2024―Feb―27 Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden Evangelia Elenis, Helena Kopp Kallner, Maria A. Karalexi, David Hägg, Marie Linder, Katja Fall, et al. (+2)
12 [GO] 2024―Feb―01 Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19 Amie Scott, Wajeeha Ansari, Farid Khan, Richard Chambers, Michael Benigno, Manuela Di Fusco, et al. (+6)
13 [GO] 2024―Feb―01 Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID) Ekaterina Pazukhina, Mikhail Rumyantsev, Dina Baimukhambetova, Elena Bondarenko, Nadezhda Markina, Yasmin El-Taravi, et al. (+140)
14 [GO] 2024―Jan―11 First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study Gerd Kvale, Eirik Søfteland, Marte Jürgensen, Ane Wilhelmsen-Langeland, Anne Haugstvedt, Sigurd William Hystad, et al. (+4)
15 [GO] 2024―Jan―10 Risks of digestive diseases in long COVID: evidence from a population-based cohort study Yuying Ma, Lijun Zhang, Rui Wei, Weiyu Dai, Ruijie Zeng, Dongling Luo, et al. (+8)
16 [GO] 2023―Dec―14 Have there been sustained impacts of the COVID-19 pandemic on trends in smoking prevalence, uptake, quitting, use of treatment, and relapse? A monthly population study in England, 2017-2022 Sarah E. Jackson, Harry Tattan-Birch, Lion Shahab, Emma Beard, Jamie Brown
17 [GO] 2023―Dec―08 One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study Emma J. A. Schepens, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
18 [GO] 2023―Dec―05 Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza Ting-Hui Liu, Po-Yu Huang, Jheng-Yan Wu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Ya-Wen Tsai, Chih-Cheng Lai
19 [GO] 2023―Nov―29 Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study Maia Salholz-Hillel, Molly Pugh-Jones, Nicole Hildebrand, Tjada A. Schult, Johannes Schwietering, Peter Grabitz, et al. (+4)
20 [GO] 2023―Nov―28 Identifying patterns of reported findings on long-term cardiac complications of COVID-19: a systematic review and meta-analysis Boya Guo, Chenya Zhao, Mike Z. He, Camilla Senter, Zhenwei Zhou, Jin Peng, et al. (+6)
21 [GO] 2023―Nov―13 A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran Mahan Ghafari, Sepanta Hosseinpour, Mohammad Saeid Rezaee-Zavareh, Stefan Dascalu, Somayeh Rostamian, Kiarash Aramesh, et al. (+2)
22 [GO] 2023―Nov―08 Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study Laetitia Tan-Lhernould, Cynthia Tamandjou, Guilhem Deschamps, Johnny Platon, Cécile Sommen, Fanny Chereau, et al. (+4)
23 [GO] 2023―Oct―20 Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study Min-Taek Lee, Moon Seong Baek, Tae Wan Kim, Sun-Young Jung, Won-Young Kim
24 [GO] 2023―Oct―13 Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort Sangeetha Shyam, Jesús Francisco García-Gavilán, Indira Paz-Graniel, José J. Gaforio, Miguel Ángel Martínez-González, Dolores Corella, et al. (+46)
25 [GO] 2023―Oct―02 Return to work and health-related quality of life up to 1 year in patients hospitalized for COVID-19: the CO-FLOW study L. M. Bek, J. C. Berentschot, M. E. Hellemons, S. C. Remerie, J. van Bommel, J. G. J. V. Aerts, et al. (+20)
26 [GO] 2023―Sep―29 Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis Xiangyanyu Xu, Yanpeng Wu, Allisandra G. Kummer, Yuchen Zhao, Zexin Hu, Yan Wang, et al. (+3)
27 [GO] 2023―Sep―21 Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care Umer Syed, Anuradhaa Subramanian, David C. Wraith, Janet M. Lord, Kirsty McGee, Krishna Ghokale, et al. (+2)
28 [GO] 2023―Sep―19 Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study Felix Werner, Nikoletta Zeschick, Thomas Kühlein, Philipp Steininger, Klaus Überla, Isabelle Kaiser, et al. (+3)
29 [GO] 2023―Aug―24 Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States Fuhan Yang, Thu Nguyen-Anh Tran, Emily Howerton, Maciej F. Boni, Joseph L. Servadio
30 [GO] 2023―Aug―15 Underrepresentation of ethnic minorities in UK COVID-19 trials: comment on a recent systematic review and meta-analysis Zeynep Ersoy Guller, Frederick Green, Anna L. Goodman
31 [GO] 2023―Jul―19 Causal effects of COVID-19 on structural changes in specific brain regions: a Mendelian randomization study Shaojiong Zhou, Tao Wei, Xiaoduo Liu, Yufei Liu, Weiyi Song, Xinwei Que, et al. (+3)
32 [GO] 2023―Jul―19 Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites Deyu Zhang, Siyuan Weng, Chuanchao Xia, Yuqing Ren, Zaoqu Liu, Yudi Xu, et al. (+18)
33 [GO] 2023―Jul―19 Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UK J Kennedy, M Parker, M Seaborne, M Mhereeg, A Walker, V Walker, et al. (+4)
34 [GO] 2023―Jul―10 Estimating the delivery costs of COVID-19 vaccination using the COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool: the Lao People’s Democratic Republic experience Karene Hoi Ting Yeung, Eunkyoung Kim, Wei Aun Yap, Chansay Pathammavong, Lauren Franzel, Yu Lee Park, et al. (+3)
35 [GO] 2023―Jun―21 Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study Oleg O. Glebov, Christoph Mueller, Robert Stewart, Dag Aarsland, Gayan Perera
36 [GO] 2023―Jun―20 Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study Lisette Warkentin, Felix Werner, Nikoletta Zeschick, Thomas Kühlein, Philipp Steininger, Klaus Überla, et al. (+3)
37 [GO] 2023―Jun―14 Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: insights from Aotearoa New Zealand Michael Bunce, Jemma L. Geoghegan, David Winter, Joep de Ligt, Siouxsie Wiles
38 [GO] 2023―Jun―14 Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response Federica Filippini, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Cesare Tomasi, et al. (+4)
39 [GO] 2023―Jun―06 Correction: Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients Flávio de Azevedo Figueiredo, Lucas Emanuel Ferreira Ramos, Rafael Tavares Silva, Daniela Ponce, Rafael Lima Rodrigues de Carvalho, Alexandre Vargas Schwarzbold, et al. (+62)
40 [GO] 2023―Apr―27 Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis Shiyao Xu, Jincheng Li, Hongyuan Wang, Fuzhen Wang, Zundong Yin, Zhifeng Wang
41 [GO] 2023―Apr―26 Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort study Fredrik Methi, Jon Michael Gran, Morten Valberg, Jonas Minet Kinge, Kjetil Telle, Karin Magnusson
42 [GO] 2023―Apr―13 Previous BCG vaccination is associated with less severe clinical progression of COVID-19 Susan Martins Pereira, Florisneide Rodrigues Barreto, Ramon Andrade de Souza, Carlos Antonio de Souza Teles Santos, Marcos Pereira, Enny Santos da Paixão, et al. (+18)
43 [GO] 2023―Apr―03 Interventions to improve well-being among children and youth aged 6-17 years during the COVID-19 pandemic: a systematic review Stephana J. Moss, Sara J. Mizen, Maia Stelfox, Rebecca Brundin Mather, Emily A. FitzGerald, Perri Tutelman, et al. (+5)
44 [GO] 2023―Mar―29 Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis Mayur Murali, Leher Gumber, Hannah Jethwa, Divolka Ganesh, Jamie Hartmann-Boyce, Harpreet Sood, et al. (+2)
45 [GO] 2023―Mar―29 Rapid antigen-based and rapid molecular tests for the detection of SARS-CoV-2: a rapid review with network meta-analysis of diagnostic test accuracy studies Areti Angeliki Veroniki, Andrea C. Tricco, Jennifer Watt, Sofia Tsokani, Paul A. Khan, Charlene Soobiah, et al. (+18)
46 [GO] 2023―Mar―16 Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study Rachael Pung, Hannah E. Clapham, Timothy W. Russell, Vernon J. Lee, Adam J. Kucharski
47 [GO] 2023―Mar―08 Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries Yang Liu, Simon R. Procter, Carl A. B. Pearson, Andrés Madriz Montero, Sergio Torres-Rueda, Elias Asfaw, et al. (+9)
48 [GO] 2023―Feb―28 Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19 Jie Wei, Weiya Zhang, Michael Doherty, Zachary S. Wallace, Jeffrey A. Sparks, Na Lu, et al. (+4)
49 [GO] 2023―Feb―16 Correction: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
50 [GO] 2023―Feb―16 Coding long COVID: characterizing a new disease through an ICD-10 lens Emily R. Pfaff, Charisse Madlock-Brown, John M. Baratta, Abhishek Bhatia, Hannah Davis, Andrew Girvin, et al. (+10)
51 [GO] 2023―Jan―19 Ethnic inequalities in the impact of COVID-19 on primary care consultations: a time series analysis of 460,084 individuals with multimorbidity in South London Alice McGreevy, Marina Soley-Bori, Mark Ashworth, Yanzhong Wang, Emma Rezel-Potts, Stevo Durbaba, et al. (+2)
52 [GO] 2023―Jan―19 Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England Ellen Brooks-Pollock, Kate Northstone, Lorenzo Pellis, Francesca Scarabel, Amy Thomas, Emily Nixon, et al. (+6)
53 [GO] 2023―Jan―08 Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study Matthew L. Bosworth, Tamanna Ahmed, Tim Larsen, Luke Lorenzi, Jasper Morgan, Raghib Ali, et al. (+8)
54 [GO] 2023―Jan―04 Individual and neighborhood risk factors of hospital admission and death during the COVID-19 pandemic: a population-based cohort study Max Bell, Maria-Pia Hergens, Stefan Fors, Per Tynelius, Antonio Ponce de Leon, Anton Lager
55 [GO] 2022―Dec―08 Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, et al. (+8)
56 [GO] 2022―Nov―30 Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test Manjula D. Nugawela, Terence Stephenson, Roz Shafran, Bianca L. De Stavola, Shamez N. Ladhani, Ruth Simmons, et al. (+8)
57 [GO] 2022―Nov―30 Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, Chankyu Lee, Jeong-Yoon Lee, Kazutoyo Miura, et al. (+11)
58 [GO] 2022―Nov―25 Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression Marek Petráš, Roman Máčalík, Daniela Janovská, Alexander M. Čelko, Jana Dáňová, Eliška Selinger, et al. (+6)
59 [GO] 2022―Nov―24 Prognostic models for COVID-19 needed updating to warrant transportability over time and space David van Klaveren, Theodoros P. Zanos, Jason Nelson, Todd J. Levy, Jinny G. Park, Isabel R. A. Retel Helmrich, et al. (+5)
60 [GO] 2022―Nov―24 Economic evaluation of COVID-19 rapid antigen screening programs in the workplace Thomas N. Vilches, Ellen Rafferty, Chad R. Wells, Alison P. Galvani, Seyed M. Moghadas
61 [GO] 2022―Nov―16 Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
62 [GO] 2022―Nov―15 Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis Ting Zhang, Qimin Mei, Zhaocai Zhang, Joseph Harold Walline, Yecheng Liu, Huadong Zhu, Shuyang Zhang
63 [GO] 2022―Nov―15 Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants Yan Wang, Kaiyuan Sun, Zhaomin Feng, Lan Yi, Yanpeng Wu, Hengcong Liu, et al. (+4)
64 [GO] 2022―Nov―14 Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries C. Finn McQuaid, Marc Y. R. Henrion, Rachael M. Burke, Peter MacPherson, Rebecca Nzawa-Soko, Katherine C. Horton
65 [GO] 2022―Nov―08 Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines Ishmeala Rigby, Melina Michelen, Vincent Cheng, Andrew Dagens, Dania Dahmash, Samuel Lipworth, et al. (+11)
66 [GO] 2022―Nov―08 Lower transmissibility of SARS-CoV-2 among asymptomatic cases: evidence from contact tracing data in Oslo, Norway Fredrik Methi, Elisabeth Henie Madslien
67 [GO] 2022―Nov―02 Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study Anouk Verveen, Elke Wynberg, Hugo D. G. van Willigen, Udi Davidovich, Anja Lok, Eric P. Moll van Charante, et al. (+49)
68 [GO] 2022―Oct―25 Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis Bingyi Yang, Xiaotong Huang, Huizhi Gao, Nancy H. Leung, Tim K. Tsang, Benjamin J. Cowling
69 [GO] 2022―Oct―24 Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study Ewoud Schuit, Roderick P. Venekamp, Irene K. Veldhuijzen, Wouter van den Bijllaardt, Suzan D. Pas, Joep J. J. M. Stohr, et al. (+12)
70 [GO] 2022―Oct―20 Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death Zhuoying Huang, Shuangfei Xu, Jiechen Liu, Linlin Wu, Jing Qiu, Nan Wang, et al. (+8)
71 [GO] 2022―Oct―14 Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+9)
72 [GO] 2022―Oct―13 Sustained seropositivity up to 20.5 months after COVID-19 Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Rocío Rubio, Gemma Ruiz-Olalla, Josep Vidal-Alaball, et al. (+14)
73 [GO] 2022―Oct―12 Characterising social contacts under COVID-19 control measures in Africa Zlatina Dobreva, Amy Gimma, Hana Rohan, Benjamin Djoudalbaye, Akhona Tshangela, Christopher I. Jarvis, et al. (+2)
74 [GO] 2022―Oct―10 Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study Neyme Veli, Christopher A. Martin, Katherine Woolf, Joshua Nazareth, Daniel Pan, Amani Al-Oraibi, et al. (+18)
75 [GO] 2022―Oct―05 The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung T. Tran, Siri Mjaaland, et al. (+13)
76 [GO] 2022―Oct―03 Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa Kesego Tapela, Fatima O. Oyawoye, Charles Ochieng’ Olwal, Precious C. Opurum, Jones Amo Amponsah, Kekeli Aku Lumor Segbedzi, et al. (+13)
77 [GO] 2022―Sep―27 A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, et al. (+8)
78 [GO] 2022―Sep―26 Transparency and reporting characteristics of COVID-19 randomized controlled trials Philipp Kapp, Laura Esmail, Lina Ghosn, Philippe Ravaud, Isabelle Boutron
79 [GO] 2022―Sep―21 The UK Coronavirus Job Retention Scheme and smoking, alcohol consumption and vaping during the COVID-19 pandemic: evidence from eight longitudinal population surveys Michael J. Green, Jane Maddock, Giorgio Di Gessa, Bożena Wielgoszewska, Sam Parsons, Gareth J. Griffith, et al. (+13)
80 [GO] 2022―Sep―20 Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study Anton Barchuk, Mikhail Cherkashin, Anna Bulina, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, et al. (+3)
81 [GO] 2022―Sep―16 SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, Gemma Castaño-Vinyals, Rocío Rubio, Marta Vidal, et al. (+20)
82 [GO] 2022―Sep―14 Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic Marc-Antoine Sanchez, Basile Fuchs, Pascale Tubert-Bitter, Anne-Sophie Mariet, Fabrice Jollant, Aurélie Mayet, Catherine Quantin
83 [GO] 2022―Sep―02 Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021 Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, et al. (+3)
84 [GO] 2022―Sep―02 Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients Flávio de Azevedo Figueiredo, Lucas Emanuel Ferreira Ramos, Rafael Tavares Silva, Daniela Ponce, Rafael Lima Rodrigues de Carvalho, Alexandre Vargas Schwarzbold, et al. (+62)
85 [GO] 2022―Aug―23 Genetic predispositions to psychiatric disorders and the risk of COVID-19 Wenwen Chen, Yu Zeng, Chen Suo, Huazhen Yang, Yilong Chen, Can Hou, et al. (+8)
86 [GO] 2022―Jul―30 Correction: The UK Coronavirus Job Retention Scheme and diet, physical activity, and sleep during the COVID-19 pandemic: evidence from eight longitudinal population surveys Bożena Wielgoszewska, Jane Maddock, Michael J. Green, Giorgio Di Gessa, Sam Parsons, Gareth J. Griffith, et al. (+12)
87 [GO] 2022―Jul―05 Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY Amelia Green, Helen Curtis, William Hulme, Elizabeth Williamson, Helen McDonald, Krishnan Bhaskaran, et al. (+35)
88 [GO] 2022―Jun―28 Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro Tomabu Adjobimey, Julia Meyer, Vedrana Terkeš, Marijo Parcina, Achim Hoerauf
89 [GO] 2022―Jun―20 Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas Jacob Blankenberger, Marco Kaufmann, Emiliano Albanese, Rebecca Amati, Daniela Anker, Anne-Linda Camerini, et al. (+14)
90 [GO] 2022―May―23 Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic Aurélie Godbout, Mélanie Drolet, Myrto Mondor, Marc Simard, Chantal Sauvageau, Gaston De Serres, Marc Brisson
91 [GO] 2022―May―23 Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis Baoqi Zeng, Le Gao, Qingxin Zhou, Kai Yu, Feng Sun
92 [GO] 2022―May―18 An assessment of the vaccination of school-aged children in England against SARS-CoV-2 Matt J. Keeling, Sam E. Moore
93 [GO] 2022―May―04 Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, et al. (+10)
94 [GO] 2022―May―02 The COVID-19 pandemic in the African continent Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, Felix Ocom, Joseph F. Wamala, Kwadwo A. Kusi, et al. (+4)
95 [GO] 2022―Apr―26 Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis Nanina Anderegg, Radoslaw Panczak, Matthias Egger, Nicola Low, Julien Riou
96 [GO] 2022―Apr―15 Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia’s surveillance system performance Kamalini Lokuge, Katina D’Onise, Emily Banks, Tatum Street, Sydney Jantos, Mohana Baptista, Kathryn Glass
97 [GO] 2022―Apr―06 The UK Coronavirus Job Retention Scheme and diet, physical activity, and sleep during the COVID-19 pandemic: evidence from eight longitudinal population surveys Bożena Wielgoszewska, Jane Maddock, Michael J. Green, Giorgio Di Gessa, Sam Parsons, Gareth J. Griffith, et al. (+12)
98 [GO] 2022―Apr―05 CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study Enny S. Paixao, Kerry L. M. Wong, Flavia Jôse Oliveira Alves, Vinicius de Araújo Oliveira, Thiago Cerqueira-Silva, Juracy Bertoldo Júnior, et al. (+9)
99 [GO] 2022―Apr―04 Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study Zhiyuan Chen, Wen Zheng, Qianhui Wu, Xinghui Chen, Cheng Peng, Yuyang Tian, et al. (+14)
100 [GO] 2022―Mar―29 Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients Emily Toscano-Guerra, Mónica Martínez Gallo, Iria Arrese-Muñoz, Anna Giné, Noelia Díaz-Troyano, Pablo Gabriel-Medina, et al. (+10)
101 [GO] 2022―Mar―28 AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2 Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, et al. (+17)
102 [GO] 2022―Mar―17 Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization Carlos King Ho Wong, Xi Xiong, Kristy Tsz Kwan Lau, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+6)
103 [GO] 2022―Mar―03 Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Henrike Maass, et al. (+22)
104 [GO] 2022―Mar―02 Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases Luuk Wieske, Laura Y. L. Kummer, Koos P. J. van Dam, Eileen W. Stalman, Anneke J. van der Kooi, Joost Raaphorst, et al. (+47)
105 [GO] 2022―Feb―24 Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study Roderick P. Venekamp, Irene K. Veldhuijzen, Karel G. M. Moons, Wouter van den Bijllaardt, Suzan D. Pas, Esther B. Lodder, et al. (+12)
106 [GO] 2022―Feb―23 The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave Daniela Basso, Ada Aita, Filippo Navaglia, Paola Mason, Stefania Moz, Alessio Pinato, et al. (+9)
107 [GO] 2022―Feb―23 Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study Mario Rivera-Izquierdo, Antonio Jesús Láinez-Ramos-Bossini, Inmaculada Guerrero-Fernández de Alba, Rocío Ortiz-González-Serna, Álvaro Serrano-Ortiz, Nicolás Francisco Fernández-Martínez, et al. (+2)
108 [GO] 2022―Feb―22 Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) Mohammad Talaei, Sian Faustini, Hayley Holt, David A. Jolliffe, Giulia Vivaldi, Matthew Greenig, et al. (+12)
109 [GO] 2022―Feb―21 Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level Sophie Meakin, Sam Abbott, Nikos Bosse, James Munday, Hugo Gruson, Joel Hellewell, et al. (+46)
110 [GO] 2022―Feb―18 A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial Jorge B. Cannata-Andía, Augusto Díaz-Sottolano, Pehuén Fernández, Carmen Palomo-Antequera, Pablo Herrero-Puente, Ricardo Mouzo, et al. (+15)
111 [GO] 2022―Feb―18 Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis George J. Milne, Julian Carrivick, David Whyatt
112 [GO] 2022―Feb―08 Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study Giovanni Corrao, Matteo Franchi, Federico Rea, Danilo Cereda, Antonio Barone, Catia Rosanna Borriello, et al. (+13)
113 [GO] 2022―Feb―07 Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia Donal Bisanzio, Richard Reithinger, Ada Alqunaibet, Sami Almudarra, Reem F. Alsukait, Di Dong, et al. (+3)
114 [GO] 2022―Jan―31 Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, et al. (+9)
115 [GO] 2022―Jan―28 Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint Xinhua Chen, Wei Wang, Xinghui Chen, Qianhui Wu, Ruijia Sun, Shijia Ge, et al. (+5)
116 [GO] 2022―Jan―26 Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Vittoria Colizza, Yazdan Yazdanpanah, Arnaud Fontanet, et al. (+2)
117 [GO] 2022―Jan―25 Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2 Rahul Ukey, Natalie Bruiners, Hridesh Mishra, Pankaj K. Mishra, Deborah McCloskey, Alberta Onyuka, et al. (+7)
118 [GO] 2022―Jan―21 Humoral immune response after different SARS-CoV-2 vaccination regimens Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
119 [GO] 2022―Jan―20 Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients Zhonghan Sun, Zhi-Gang Song, Chenglin Liu, Shishang Tan, Shuchun Lin, Jiajun Zhu, et al. (+13)
120 [GO] 2022―Jan―19 Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production Michael Müller, Johann Volzke, Behnam Subin, Silke Müller, Martina Sombetzki, Emil C. Reisinger, Brigitte Müller-Hilke
121 [GO] 2022―Jan―14 Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, Miriam A. Lynn, Zelalem A. Mekonnen, Arthur Eng Lip Yeow, et al. (+14)
122 [GO] 2022―Jan―13 Modelling upper respiratory viral load dynamics of SARS-CoV-2 Joseph D. Challenger, Cher Y. Foo, Yue Wu, Ada W. C. Yan, Mahdi Moradi Marjaneh, Felicity Liew, et al. (+3)
123 [GO] 2021―Dec―07 Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study Wenlong Zhu, Mengxi Zhang, Jinhua Pan, Ye Yao, Weibing Wang
124 [GO] 2021―Dec―01 Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review Nuru Saadi, Y-Ling Chi, Srobana Ghosh, Rosalind M. Eggo, Ciara V. McCarthy, Matthew Quaife, et al. (+3)
125 [GO] 2021―Nov―30 Within- and across-day patterns of interplay between depressive symptoms and related psychopathological processes: a dynamic network approach during the COVID-19 pandemic Omid V. Ebrahimi, Julian Burger, Asle Hoffart, Sverre Urnes Johnson
126 [GO] 2021―Nov―30 Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort Mélanie Deschasaux-Tanguy, Bernard Srour, Laurent Bourhis, Nathalie Arnault, Nathalie Druesne-Pecollo, Younes Esseddik, et al. (+88)
127 [GO] 2021―Nov―23 Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain Carlota Dobaño, Selena Alonso, Mariona Fernández de Sevilla, Marta Vidal, Alfons Jiménez, Gemma Pons Tomas, et al. (+29)
128 [GO] 2021―Nov―19 SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 Jonathan Mandolo, Jacquline Msefula, Marc Y. R. Henrion, Comfort Brown, Brewster Moyo, Aubrey Samon, et al. (+17)
129 [GO] 2021―Nov―16 COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank Can Hou, Yihan Hu, Huazhen Yang, Wenwen Chen, Yu Zeng, Zhiye Ying, et al. (+6)
130 [GO] 2021―Nov―09 Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study Kathleen M. O’Reilly, Frank Sandman, David Allen, Christopher I. Jarvis, Amy Gimma, Amy Douglas, et al. (+8)
131 [GO] 2021―Oct―18 Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England Thomas F. D. Mason, Matt Whitston, Jack Hodgson, Ruth E. Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
132 [GO] 2021―Oct―14 Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study Philipp Kohler, Sabine Güsewell, Marco Seneghini, Thomas Egger, Onicio Leal, Angela Brucher, et al. (+15)
133 [GO] 2021―Oct―14 Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany-an analysis based on the COVIMOD study Damilola Victoria Tomori, Nicole Rübsamen, Tom Berger, Stefan Scholz, Jasmin Walde, Ian Wittenberg, et al. (+6)
134 [GO] 2021―Oct―01 Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections Timothy Farinholt, Harsha Doddapaneni, Xiang Qin, Vipin Menon, Qingchang Meng, Ginger Metcalf, et al. (+9)
135 [GO] 2021―Sep―29 SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries Frederik Verelst, Lisa Hermans, Sarah Vercruysse, Amy Gimma, Pietro Coletti, Jantien A. Backer, et al. (+11)
136 [GO] 2021―Sep―27 Evolving phenotypes of non-hospitalized patients that indicate long COVID Hossein Estiri, Zachary H. Strasser, Gabriel A. Brat, Yevgeniy R. Semenov, James R. Aaron, Giuseppe Agapito, et al. (+201)
137 [GO] 2021―Sep―24 The risk of COVID-19 in survivors of domestic violence and abuse Joht Singh Chandan, Anuradhaa Subramanian, Jaidev Kaur Chandan, Krishna M. Gokhale, Alecs Vitoc, Julie Taylor, et al. (+3)
138 [GO] 2021―Sep―17 Exiting the pandemic: Singapore style Dale Fisher, Kenneth Mak
139 [GO] 2021―Sep―14 In for the long-haul? Seropositivity and sequelae 1 year post COVID-19 Jeremy Werner Deuel, Patricia Schlagenhauf
140 [GO] 2021―Sep―10 Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data James D. Munday, Christopher I. Jarvis, Amy Gimma, Kerry L. M. Wong, Kevin van Zandvoort, Yang Liu, et al. (+42)
141 [GO] 2021―Aug―30 The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study Harrison Wilde, Thomas Mellan, Iwona Hawryluk, John M. Dennis, Spiros Denaxas, Christina Pagel, et al. (+5)
142 [GO] 2021―Aug―27 Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence Marina Treskova-Schwarzbach, Laura Haas, Sarah Reda, Antonia Pilic, Anna Borodova, Kasra Karimi, et al. (+7)
143 [GO] 2021―Aug―27 Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study Thi Mui Pham, Hannan Tahir, Janneke H. H. M. van de Wijgert, Bastiaan R. Van der Roest, Pauline Ellerbroek, Marc J. M. Bonten, et al. (+2)
144 [GO] 2021―Aug―23 Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients Ioannis P. Trougakos, Evangelos Terpos, Christina Zirou, Aimilia D. Sklirou, Filia Apostolakou, Sentiljana Gumeni, et al. (+9)
145 [GO] 2021―Aug―22 Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic Terence J. Quin, Jennifer K. Burton, Ben Carter, Nicola Cooper, Kerry Dwan, Ryan Field, et al. (+9)
146 [GO] 2021―Aug―12 SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study Simon R. Procter, Kaja Abbas, Stefan Flasche, Ulla Griffiths, Brittany Hagedorn, Kathleen M. O’Reilly, et al. (+50)
147 [GO] 2021―Aug―09 One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection Yanfei Chen, Cheng Ding, Ling Yu, Wanru Guo, Xuewen Feng, Liang Yu, et al. (+14)
148 [GO] 2021―Jul―28 Evaluation of the safety profile of COVID-19 vaccines: a rapid review Qianhui Wu, Matthew Z. Dudley, Xinghui Chen, Xufang Bai, Kaige Dong, Tingyu Zhuang, et al. (+2)
149 [GO] 2021―Jul―26 Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals Elizabeth Fraley, Cas LeMaster, Eric Geanes, Dithi Banerjee, Santosh Khanal, Elin Grundberg, et al. (+2)
150 [GO] 2021―Jul―14 Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study Lijuan Xiong, Qian Li, Xiongjing Cao, Huangguo Xiong, Ming Huang, Fengwen Yang, et al. (+14)
151 [GO] 2021―Jul―13 Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts Thu Nguyen-Anh Tran, Nathan B. Wikle, Emmy Albert, Haider Inam, Emily Strong, Karel Brinda, et al. (+8)
152 [GO] 2021―Jul―09 The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases Muna Affara, Hakim Idris Lagu, Emmanuel Achol, Richard Karamagi, Neema Omari, Grace Ochido, et al. (+30)
153 [GO] 2021―Jun―28 Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19 Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Josep Vidal-Alaball, Gemma Ruiz-Olalla, Marta Vidal, et al. (+12)
154 [GO] 2021―Jun―23 Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study Paul M. McKeigue, David A. McAllister, David Caldwell, Ciara Gribben, Jen Bishop, Stuart McGurnaghan, et al. (+9)
155 [GO] 2021―Jun―18 Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout Bimandra A. Djaafara, Charles Whittaker, Oliver J. Watson, Robert Verity, Nicholas F. Brazeau, Dwi Oktavia, et al. (+16)
156 [GO] 2021―Jun―07 An analysis of school absences in England during the COVID-19 pandemic Emma Southall, Alex Holmes, Edward M. Hill, Benjamin D. Atkins, Trystan Leng, Robin N. Thompson, et al. (+3)
157 [GO] 2021―Jun―04 Renin-angiotensin system blockers and COVID-19 Emmanuelle Vidal-Petiot, Nathalie Gault
158 [GO] 2021―May―20 Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study Álvaro Romero-Duarte, Mario Rivera-Izquierdo, Inmaculada Guerrero-Fernández de Alba, Marina Pérez-Contreras, Nicolás Francisco Fernández-Martínez, Rafael Ruiz-Montero, et al. (+5)
159 [GO] 2021―May―17 Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales Mohammad A. Alsallakh, Shanya Sivakumaran, Sharon Kennedy, Eleftheria Vasileiou, Ronan A. Lyons, Chris Robertson, et al. (+2)
160 [GO] 2021―May―12 Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study Francisco J. de Abajo, Antonio Rodríguez-Miguel, Sara Rodríguez-Martín, Victoria Lerma, Alberto García-Lledó
161 [GO] 2021―May―07 Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study Lloyd A. C. Chapman, Margot Kushel, Sarah N. Cox, Ashley Scarborough, Caroline Cawley, Trang Q. Nguyen, et al. (+4)
162 [GO] 2021―Apr―29 What neurological and psychiatric effects does COVID-19 have on its survivors? Alexios-Fotios A. Mentis
163 [GO] 2021―Apr―27 Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections Joel Hellewell, Timothy W. Russell, Rupert Beale, Gavin Kelly, Catherine Houlihan, Eleni Nastouli, Adam J. Kucharski
164 [GO] 2021―Apr―14 Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing Michael A. Johansson, Hannah Wolford, Prabasaj Paul, Pamela S. Diaz, Tai-Ho Chen, Clive M. Brown, et al. (+2)
165 [GO] 2021―Apr―09 Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia Filippo Trentini, Giorgio Guzzetta, Margherita Galli, Agnese Zardini, Fabio Manenti, Giovanni Putoto, et al. (+8)
166 [GO] 2021―Mar―31 Research priorities for Long Covid: refined through an international multi-stakeholder forum Gail Carson
167 [GO] 2021―Mar―24 Greater public health impact of COVID-19 antigen detection tests Akiko Kowada
168 [GO] 2021―Mar―24 Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study Shiu Lun Au Yeung, Jie V Zhao, C Mary Schooling
169 [GO] 2021―Mar―09 Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis Saskia Ricks, Emily A. Kendall, David W. Dowdy, Jilian A. Sacks, Samuel G. Schumacher, Nimalan Arinaminpathy
170 [GO] 2021―Mar―05 Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study Marcello Morciano, Jonathan Stokes, Evangelos Kontopantelis, Ian Hall, Alex J. Turner
171 [GO] 2021―Feb―23 Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic Terence J. Quinn, Jennifer K. Burton, Ben Carter, Nicola Cooper, Kerry Dwan, Ryan Field, et al. (+9)
172 [GO] 2021―Feb―22 Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study Paul M. McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, David McAllister, et al. (+11)
173 [GO] 2021―Feb―20 Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission K. Lokuge, E. Banks, S. Davis, L. Roberts, T. Street, D. O’Donovan, et al. (+2)
174 [GO] 2021―Feb―20 The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment Christopher I. Jarvis, Amy Gimma, Kevin van Zandvoort, Kerry L. M. Wong, W. John Edmunds
175 [GO] 2021―Feb―10 Who should be prioritized for COVID-19 vaccination in China? A descriptive study Juan Yang, Wen Zheng, Huilin Shi, Xuemei Yan, Kaige Dong, Qian You, et al. (+7)
176 [GO] 2021―Feb―05 COVID-19 pandemic and violence: rising risks and decreasing urgent care-seeking for sexual assault and domestic violence survivors Katherine A. Muldoon, Kathryn M. Denize, Robert Talarico, Deshayne B. Fell, Agnes Sobiesiak, Melissa Heimerl, Kari Sampsel
177 [GO] 2021―Feb―05 The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories Yang Liu, Christian Morgenstern, James Kelly, Rachel Lowe, Mark Jit
178 [GO] 2021―Feb―03 The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya C. N. Mburu, J. Ojal, R. Chebet, D. Akech, B. Karia, J. Tuju, et al. (+12)
179 [GO] 2021―Jan―28 When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition Paula Littlejohn, B. Brett Finlay
180 [GO] 2021―Jan―28 Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures Sahamoddin Khailaie, Tanmay Mitra, Arnab Bandyopadhyay, Marta Schips, Pietro Mascheroni, Patrizio Vanella, et al. (+3)
181 [GO] 2021―Jan―22 Efficient SARS-CoV-2 surveillance strategies to prevent deadly outbreaks in vulnerable populations Damon J. A. Toth, Karim Khader
182 [GO] 2021―Jan―21 Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study Ewan Carr, Rebecca Bendayan, Daniel Bean, Matt Stammers, Wenjuan Wang, Huayu Zhang, et al. (+42)
183 [GO] 2021―Jan―12 Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19 Francesco Pinotti, Paul S. Wikramaratna, Uri Obolski, Robert S. Paton, Daniel S. C. Damineli, Luiz C. J. Alcantara, et al. (+3)
184 [GO] 2020―Dec―18 Cardiovascular implications of COVID-19 versus influenza infection: a review Muhammad Shahzeb Khan, Izza Shahid, Stefan D. Anker, Scott D. Solomon, Orly Vardeny, Erin D. Michos, et al. (+2)
185 [GO] 2020―Dec―18 Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study A. Vilches-Moraga, A. Price, P. Braude, L. Pearce, R. Short, A. Verduri, et al. (+11)
186 [GO] 2020―Dec―17 Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study Theodora Oikonomidi, Isabelle Boutron, Olivier Pierre, Guillaume Cabanac, Philippe Ravaud
187 [GO] 2020―Dec―16 Use of short message service in at-home COVID-19 patient management Paul Loubet, Christian Czeschan, Matthieu Sintes, Albert Sotto, Didier Laureillard
188 [GO] 2020―Dec―08 Optimizing COVID-19 surveillance in long-term care facilities: a modelling study David R. M. Smith, Audrey Duval, Koen B. Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, et al. (+2)
189 [GO] 2020―Nov―25 Evidence for treatment with estradiol for women with SARS-CoV-2 infection Ute Seeland, Flaminia Coluzzi, Maurizio Simmaco, Cameron Mura, Philip E. Bourne, Max Heiland, et al. (+2)
190 [GO] 2020―Nov―16 Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, et al. (+19)
191 [GO] 2020―Nov―10 Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank Fanny Petermann-Rocha, Peter Hanlon, Stuart R. Gray, Paul Welsh, Jason M. R. Gill, Hamish Foster, et al. (+11)
192 [GO] 2020―Nov―04 Impact of Covid-19 in pregnancy on mother’s psychological status and infant’s neurobehavioral development: a longitudinal cohort study in China Yuanyuan Wang, Lian Chen, Tianchen Wu, Huifeng Shi, Qin Li, Hai Jiang, et al. (+5)
193 [GO] 2020―Nov―04 At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data Sue Mallett, A. Joy Allen, Sara Graziadio, Stuart A. Taylor, Naomi S. Sakai, Kile Green, et al. (+14)
194 [GO] 2020―Oct―29 Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings
195 [GO] 2020―Oct―23 Frailty as an integrative marker of physiological vulnerability in the era of COVID-19 Qian-Li Xue
196 [GO] 2020―Oct―22 Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections Timothy W. Russell, Nick Golding, Joel Hellewell, Sam Abbott, Lawrence Wright, Carl A. B. Pearson, et al. (+7)
197 [GO] 2020―Oct―19 Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China Rong Yang, Hui Mei, Tongzhang Zheng, Qiang Fu, Yiming Zhang, Stephen Buka, et al. (+9)
198 [GO] 2020―Oct―16 Adapting hospital capacity to meet changing demands during the COVID-19 pandemic Ruth McCabe, Nora Schmit, Paula Christen, Josh C. D’Aeth, Alessandra Løchen, Dheeya Rizmie, et al. (+9)
199 [GO] 2020―Oct―14 Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study Kevin van Zandvoort, Christopher I. Jarvis, Carl A. B. Pearson, Nicholas G. Davies, Ruwan Ratnayake, Timothy W. Russell, et al. (+5)
200 [GO] 2020―Oct―09 Response to COVID-19 in South Korea and implications for lifting stringent interventions Amy Dighe, Lorenzo Cattarino, Gina Cuomo-Dannenburg, Janetta Skarp, Natsuko Imai, Sangeeta Bhatia, et al. (+35)
201 [GO] 2020―Oct―05 The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements Matthew Quaife, Kevin van Zandvoort, Amy Gimma, Kashvi Shah, Nicky McCreesh, Kiesha Prem, et al. (+7)
202 [GO] 2020―Sep―12 Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
203 [GO] 2020―Sep―10 Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions Brennan C. Kahan, Tim P. Morris, Ian R. White, Conor D. Tweed, Suzie Cro, Darren Dahly, et al. (+4)
204 [GO] 2020―Sep―08 Preparing for a pandemic: highlighting themes for research funding and practice-perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Alice Norton, Louise Sigfrid, Adeniyi Aderoba, Naima Nasir, Peter G. Bannister, Shelui Collinson, et al. (+7)
205 [GO] 2020―Sep―07 The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study Yao Ma, Lisha Hou, Xiufang Yang, Zhixin Huang, Xue Yang, Na Zhao, et al. (+5)
206 [GO] 2020―Sep―04 An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City Richard S. Whittle, Ana Diaz-Artiles
207 [GO] 2020―Sep―03 COVID-19 length of hospital stay: a systematic review and data synthesis Eleanor M. Rees, Emily S. Nightingale, Yalda Jafari, Naomi R. Waterlow, Samuel Clifford, Carl A. B. Pearson, et al. (+4)
208 [GO] 2020―Aug―21 Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009 Amanda M. Rojek, Genevieve E. Martin, Peter W. Horby
209 [GO] 2020―Aug―19 The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study Billy J. Quilty, Charlie Diamond, Yang Liu, Hamish Gibbs, Timothy W. Russell, Christopher I. Jarvis, et al. (+7)
210 [GO] 2020―Aug―19 Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? Niraj Shenoy, Rebecca Luchtel, Perminder Gulani
211 [GO] 2020―Aug―14 Indirect implications of COVID-19 prevention strategies on non-communicable diseases Pietro A. Modesti, Jiguang Wang, Albertino Damasceno, Charles Agyemang, Luc Van Bortel, Alexandre Persu, et al. (+6)
212 [GO] 2020―Aug―06 Epidemiological and clinical features of pediatric COVID-19 Cheng-Xian Guo, Li He, Ji-Ye Yin, Xiang-Guang Meng, Wei Tan, Guo-Ping Yang, et al. (+4)
213 [GO] 2020―Jul―31 “The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic Hugo López-Pelayo, Henri-Jean Aubin, Colin Drummond, Geert Dom, Francisco Pascual, Jürgen Rehm, et al. (+3)
214 [GO] 2020―Jul―30 Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies Laura Di Domenico, Giulia Pullano, Chiara E. Sabbatini, Pierre-Yves Boëlle, Vittoria Colizza
215 [GO] 2020―Jul―30 Identifying and combating the impacts of COVID-19 on malaria Stephen J. Rogerson, James G. Beeson, Moses Laman, Jeanne Rini Poespoprodjo, Timothy William, Julie A. Simpson, Ric N. Price
216 [GO] 2020―Jul―24 Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada Elaheh Abdollahi, Margaret Haworth-Brockman, Yoav Keynan, Joanne M. Langley, Seyed M. Moghadas
217 [GO] 2020―Jul―15 Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
218 [GO] 2020―Jul―15 Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020 Kenji Mizumoto, Katsushi Kagaya, Gerardo Chowell
219 [GO] 2020―Jul―15 Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic Ioannis Kyrou, Emmanouil Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, Harpal S. Randeva
220 [GO] 2020―Jul―15 Systems and implementation science should be part of the COVID-19 response in low resource settings Mike English, Mosa Moshabela, Jacinta Nzinga, Edwine Barasa, Benjamin Tsofa, Bruno Marchal, Margaret E Kruk
221 [GO] 2020―Jul―15 Projected geographic disparities in healthcare worker absenteeism from COVID-19 school closures and the economic feasibility of child care subsidies: a simulation study Elizabeth T. Chin, Benjamin Q. Huynh, Nathan C. Lo, Trevor Hastie, Sanjay Basu
222 [GO] 2020―Jul―15 New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis Yuan Hou, Junfei Zhao, William Martin, Asha Kallianpur, Mina K. Chung, Lara Jehi, et al. (+4)
223 [GO] 2020―Jul―15 Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
224 [GO] 2020―Jul―01 Ethnicity and COVID-19 infection: are the pieces of the puzzle falling into place? Rachel H. Mulholland, Ian P. Sinha
225 [GO] 2020―Jun―29 Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales Mark D. Verhagen, David M. Brazel, Jennifer Beam Dowd, Ilya Kashnitsky, Melinda C. Mills
226 [GO] 2020―Jun―25 Rapid publications risk the integrity of science in the era of COVID-19 N. Bagdasarian, G. B. Cross, D. Fisher
227 [GO] 2020―Jun―25 A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 Andrea Torneri, Pieter Libin, Joris Vanderlocht, Anne-Mieke Vandamme, Johan Neyts, Niel Hens
228 [GO] 2020―Jun―25 Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines Jillian C. Kohler, Tim K. Mackey
229 [GO] 2020―Jun―25 COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease Simon E. Brill, Hannah C. Jarvis, Ezgi Ozcan, Thomas L. P. Burns, Rabia A. Warraich, Lisa J. Amani, et al. (+4)
230 [GO] 2020―Jun―25 Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review Louise Sigfrid, Katherine Maskell, Peter G. Bannister, Sharif A. Ismail, Shelui Collinson, Sadie Regmi, et al. (+7)
231 [GO] 2020―Jun―09 COVID-19 cancer conundrum-evidence driving decisions or the lack of it? Nalinie Joharatnam-Hogan, Khurum Khan
232 [GO] 2020―Jun―08 Responding to COVID-19: how an academic infectious diseases division mobilized in Singapore Sophia Archuleta, Gail Cross, Jyoti Somani, Lionel Lum, Amelia Santosa, Rawan A. Alagha, et al. (+26)
233 [GO] 2020―Jun―05 The role of pulmonary CT scans for children during the COVID-19 pandemic Ian P. Sinha, Musa Kaleem
234 [GO] 2020―Jun―03 An evidence mapping and analysis of registered COVID-19 clinical trials in China Liming Lu, Fan Li, Hao Wen, Shuqi Ge, Jingchun Zeng, Wen Luo, et al. (+3)
235 [GO] 2020―Jun―03 Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020 Amna Tariq, Yiseul Lee, Kimberlyn Roosa, Seth Blumberg, Ping Yan, Stefan Ma, Gerardo Chowell
236 [GO] 2020―Jun―03 Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study Jichan Shi, Yang Li, Xian Zhou, Qiran Zhang, Xinchun Ye, Zhengxing Wu, et al. (+8)
237 [GO] 2020―Jun―03 Heterogenous COVID-19 transmission dynamics within Singapore: a clearer picture of future national responses N. Bagdasarian, D. Fisher
238 [GO] 2020―May―29 Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank Claire L. Niedzwiedz, Catherine A. O’Donnell, Bhautesh Dinesh Jani, Evangelia Demou, Frederick K. Ho, Carlos Celis-Morales, et al. (+6)
239 [GO] 2020―May―28 Diagnosis of COVID-19 in children: the story evolves R. Harwood, I. Sinha
240 [GO] 2020―May―27 Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach Alberto Aleta, Yamir Moreno
241 [GO] 2020―May―25 Epidemiological models are important tools for guiding COVID-19 interventions Robin N. Thompson
242 [GO] 2020―May―22 Africa’s response to COVID-19 Chikwe Ihekweazu, Emmanuel Agogo
243 [GO] 2020―May―07 Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK Christopher I. Jarvis, Kevin Van Zandvoort, Amy Gimma, Kiesha Prem, Petra Klepac, G. James Rubin, W. John Edmunds
244 [GO] 2020―May―06 A single-center, retrospective study of COVID-19 features in children: a descriptive investigation Huijing Ma, Jiani Hu, Jie Tian, Xi Zhou, Hui Li, Maxwell Thomas Laws, et al. (+6)
245 [GO] 2020―Apr―09 Medical education during pandemics: a UK perspective Areeb Mian, Shujhat Khan
246 [GO] 2020―Mar―18 Coronavirus: the spread of misinformation Areeb Mian, Shujhat Khan
247 [GO] 2020―Mar―13 What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures? Zhenjian He
248 [GO] 2020―Feb―28 Q&A: The novel coronavirus outbreak causing COVID-19 Dale Fisher, David Heymann

248 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.041 sec